2-27582298-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032266.5(C2orf16):c.15938G>T(p.Arg5313Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,612,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032266.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2orf16 | NM_032266.5 | c.15938G>T | p.Arg5313Leu | missense_variant | 5/5 | ENST00000447166.3 | NP_115642.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2orf16 | ENST00000447166.3 | c.15938G>T | p.Arg5313Leu | missense_variant | 5/5 | 3 | NM_032266.5 | ENSP00000403181 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 4AN: 150904Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249362Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135314
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461474Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727040
GnomAD4 genome AF: 0.0000265 AC: 4AN: 150904Hom.: 0 Cov.: 33 AF XY: 0.0000543 AC XY: 4AN XY: 73694
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.5726G>T (p.R1909L) alteration is located in exon 1 (coding exon 1) of the C2orf16 gene. This alteration results from a G to T substitution at nucleotide position 5726, causing the arginine (R) at amino acid position 1909 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at